Transgene and NEC Announce Positive Preliminary Data from Phase I Studies of TG4050, a Novel Individualized Neoantigen Cancer Vaccine Nov 23, 2021 10:14 HKT/SGT Read More
ACT Genomics and Sanomics Merge to Unleash Hong Kong's Global Potential in Healthcare Technology Nov 22, 2021 16:57 HKT/SGT Read More
冠科美博(Apollomics)Uproleselan 注射液(APL-106)用于治疗复发或难治性急性髓系白血病的中国 III 期临床试验第一例受试者成功入组 Nov 22, 2021 10:42 HKT/SGT Read More
冠科美博(Apollomics)Uproleselan 注射液(APL-106)用於治療復發或難治性急性髓系白血病的中國 III 期臨床試驗第一例受試者成功入組 Nov 22, 2021 10:41 HKT/SGT Read More
Apollomics Inc. Doses First Patient in Phase 3 Clinical Trial with APL-106 (Uproleselan Injection) in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia Nov 22, 2021 10:40 HKT/SGT Read More
Inaugural Asia Summit on Global Health highlights Hong Kong's advantages Nov 17, 2021 18:00 HKT/SGT Read More
Aohua Endoscopy, a Leading Endoscope Company Invested by Legend Capital, Successfully Listed on China's STAR Market Nov 15, 2021 17:15 HKT/SGT Read More
Olympus Launches Venture Capital Fund to Strengthen Medtech Leadership Nov 12, 2021 07:30 HKT/SGT Read More